Jun Liang

5PUBLICATIONS
12CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 17, 2026
Optimization and In Vivo Characterization of a Series of Cbl‑b Inactive-State Inhibitors.

|Jun 17, 2026
Optimization Leading to a Potent and Selective Cbl‑b Inactive-State Inhibitor That Demonstrated In Vivo Efficacy.

|Jun 19, 2024
Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate Binding.

Jun Liang, Michael J Lambrecht, Teresita L Arenzana

|Feb 21, 2022
Discovery of Inhibitors of the Lipopolysaccharide Transporter MsbA: From a Screening Hit to Potent Wild-Type Gram-Negative Activity.

Vishal A Verma, Lan Wang, Sharada S Labadie

|Jul 12, 2021
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer.

Jun Liang, Jason R Zbieg, Robert A Blake

Pageof 1

Frequent Collaborators

3 joint publications

Robin Larouche-Gauthier

2 joint publications

Michael J Lambrecht

2 joint publications

Georgette M Castanedo

2 joint publications

Peter Man-Un Ung